Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.

Multiple components of vascular alpha adrenergic responsiveness were investigated in twenty-four men with mild hypertension and eighteen age- and weight-matched normotensive controls. Arterial plasma norepinephrine (paNE), an index of sympathetic drive, was increased in hypertensives compared to normotensives (mean +/- SE), 199 +/- 24 vs. 134 +/- 11 pg/ml, P less than 0.02. The effective concentration of intra-arterial (iaNE) increasing forearm vascular resistance (FAVR) 30% (NE-EC30, an index of vascular alpha-receptor sensitivity) was similar in normotensives and hypertensives, 9 +/- 1 vs. 13 +/- 3 ng/100 ml per min, respectively, P greater than 0.3. The phentolamine induced reduction in FAVR, an index of vascular alpha-tone, was greater in hypertensives, -21.3 +/- 1.8 vs. normotensives, -14.9 +/- 1.2 U, P less than 0.02. We interpret these data as evidence for normal vascular alpha-receptor sensitivity to norepinephrine in mild hypertensives. Consequently, the increased sympathetic drive in mild hypertensives explains the elevated vascular alpha-tone. Although vascular alpha-receptor sensitivity to iaNE was normal, the FAVR responses at high doses (reactivity) were greater in hypertensives to regional infusion of both NE and angiotensin II. This "nonspecific" enhancement of vascular reactivity is probably explained by structural vascular changes in hypertensives.

[1]  R. Sivertsson.  The hemodynamic importance of structural vascular changes in essential hypertension. , 1970, Acta physiologica Scandinavica. Supplementum.

[2]  I I Chen,et al.  Development of microvascular rarefaction in the spontaneously hypertensive rat. , 1982, The American journal of physiology.

[3]  E. Haber,et al.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.

[4]  L. E. Watts,et al.  Arteriolar rarefaction in the conjunctiva of human essential hypertensives. , 1978, Microvascular research.

[5]  O. Carretero,et al.  The Loss of Endothelium‐Dependent Vascular Relaxation in Hypertension , 1986, Hypertension.

[6]  J. Uther,et al.  ‘Steady‐state’ properties of the baroreceptor‐heart rate reflex in essential hypertension in man , 1974, Clinical and experimental pharmacology & physiology.

[7]  G. Jennings,et al.  Mechanism of elevated plasma noradrenaline in the course of essential hypertension. , 1986, Journal of cardiovascular pharmacology.

[8]  G. Jennings,et al.  Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  J. Angus,et al.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin , 1983, Nature.

[10]  A. Doyle,et al.  Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. , 1959, Clinical science.

[11]  R McCarty,et al.  Relationship between plasma norepinephrine and sympathetic neural activity. , 1983, Hypertension.

[12]  S. Julius,et al.  Agreement among three different indices of sympathetic nervous system activity in essential hypertension. , 1977, Mayo Clinic proceedings.

[13]  R. Busse,et al.  Endothelium‐Mediated Dilations Contribute to the Polarity of the Arterial Wall in Vasomotion Induced by α2‐Adrenergic Agonists , 1985, Journal of cardiovascular pharmacology.

[14]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[15]  F. Bühler,et al.  Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man. , 1985, British journal of clinical pharmacology.

[16]  P. Weidmann,et al.  Pressor Factors and Cardiovascular Pressor Responsiveness in Borderline Hypertension , 1981, Hypertension.

[17]  B. Wallin,et al.  Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. , 1981, Acta physiologica Scandinavica.

[18]  J. Conway,et al.  A Vascular Abnormality in Hypertension: A Study of Blood Flow in the Forearm , 1963, Circulation.

[19]  A. Mark,et al.  Decreased Vasodilator Capacity of Forearm Resistance Vessels in Borderline Hypertension , 1980, Hypertension.

[20]  M. Mulvany,et al.  Studies of Isolated Resistance Vessels from Offspring of Essential Hypertensive Patients , 1987, Hypertension.

[21]  T. Godfraind,et al.  Role of endothelium in the contractile response of rat aorta to alpha-adrenoceptor agonists. , 1985, Clinical science.

[22]  P. Bolli,et al.  Enhanced Alpha‐Adrenoreceptor‐Mediated Vasoconstriction in Essential Hypertension , 1981, Hypertension.

[23]  R. Sivertsson,et al.  Aspects of the nature of the increased vascular resistance and increased “reactivity” to noradrenaline in hypertensive subjects , 1968 .

[24]  E. Freis.  Hemodynamics of hypertension. , 1960, Physiological reviews.

[25]  R. Neubig,et al.  Pharmacologic reduction of sympathetic drive increases platelet alpha‐2–receptor number , 1985, Clinical pharmacology and therapeutics.

[26]  S. Julius,et al.  Relation of renin status to neurogenic vascular resistance in borderline hypertension. , 1975, The American journal of cardiology.

[27]  S. Julius,et al.  Mild high-renin essential hypertension. Neurogenic human hypertension? , 1977, The New England journal of medicine.

[28]  D. Short,et al.  Morphology of the intestinal arterioles in chronic human hypertension. , 1966, British heart journal.

[29]  T. Philipp,et al.  SYMPATHETIC NERVOUS SYSTEM AND BLOOD-PRESSURE CONTROL IN ESSENTIAL HYPERTENSION , 1978, The Lancet.

[30]  B. Folkow.  The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. , 1978, Clinical science and molecular medicine. Supplement.